Patient profiles and metabolic outcomes after switching from TAFcontaining, INSTI-based triple antiretroviral therapy to dolutegravir-based two-drug regimens.

Patient profiles and metabolic outcomes after switching from TAFcontaining, INSTI-based triple antiretroviral therapy to dolutegravir-based two-drug regimens.

Por favor gira tu dispositivo para ver correctamente la web. Gracias